Cefepime/sulbactam combination as a treatment alternative for extended spectrum beta-lacatmase producing Enterobacterales: A multicentric study from India

Background: Piperacillin/tazobactam has limited activity against Enterobacterales, which concurrently express ESBL/ampC/OXA-1 beta-lactamases, which are widely prevalent in India. Thus, there is a severe dearth for carbapenem sparing options that aggravate more dependent carbapenem therapy. In the I...

Täydet tiedot

Bibliografiset tiedot

Päätekijät:	Yamuna Devi Bakthavatchalam, Dhanalakshmi Solaimalai, Anand Ashok, Harthi Ragothaman, Soniya Krishnamoorthy, Nivedhana Subburaju, Sanjay bhattacharya, Rudresh Sm, Shripad Murlidhar Taklikar, Barney Isaac, Kamini Walia, Balaji Veeraraghavan
Aineistotyyppi:	Artigo
Kieli:	Inglês
Julkaistu:	Elsevier 2024-07-01
Sarja:	Clinical Epidemiology and Global Health
Aiheet:	Cefepime Sulbactam ESBL OXA-1 Piperacillin/tazobactam Cefoperazone/sulbactam
Linkit:	http://www.sciencedirect.com/science/article/pii/S221339842400006X
Tagit:	Lisää tagi Ei tageja, Lisää ensimmäinen tagi!